Report Detail

Request for Sample of this report

Other Global IVD Infectious Disease Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4603011
    • |
  • 20 July, 2024
    • |
  • Global
    • |
  • 112 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global IVD Infectious Disease market size was valued at USD 4490.3 million in 2023 and is forecast to a readjusted size of USD 7715 million by 2030 with a CAGR of 8.0% during review period.
In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the IVD Infectious Disease industry chain, the market status of Personal (Biochemical Diagnosis, Immune Diagnosis), Commercial (Biochemical Diagnosis, Immune Diagnosis), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of IVD Infectious Disease.
Regionally, the report analyzes the IVD Infectious Disease markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global IVD Infectious Disease market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the IVD Infectious Disease market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the IVD Infectious Disease industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Biochemical Diagnosis, Immune Diagnosis).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the IVD Infectious Disease market.
Regional Analysis: The report involves examining the IVD Infectious Disease market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the IVD Infectious Disease market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to IVD Infectious Disease:
Company Analysis: Report covers individual IVD Infectious Disease players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards IVD Infectious Disease This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Personal, Commercial).
Technology Analysis: Report covers specific technologies relevant to IVD Infectious Disease. It assesses the current state, advancements, and potential future developments in IVD Infectious Disease areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the IVD Infectious Disease market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
IVD Infectious Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Biochemical Diagnosis
Immune Diagnosis
Molecular Diagnosis
Microbiological Diagnosis
Urine Diagnosis
Coagulation Diagnosis
Other
Market segment by Application
Personal
Commercial
Academic
Other
Market segment by players, this report covers
Roche Diagnostics
Abbott Laboratories
Gen-Probe
Becton Dickinson (BD)
Bio-Rad Laboratories
Siemens Healthcare
Biomérieux
Danaher
Thermo Fisher
Sysmex
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe IVD Infectious Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of IVD Infectious Disease, with revenue, gross margin and global market share of IVD Infectious Disease from 2019 to 2024.
Chapter 3, the IVD Infectious Disease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and IVD Infectious Disease market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of IVD Infectious Disease.
Chapter 13, to describe IVD Infectious Disease research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of IVD Infectious Disease
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of IVD Infectious Disease by Type
    • 1.3.1 Overview: Global IVD Infectious Disease Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global IVD Infectious Disease Consumption Value Market Share by Type in 2023
    • 1.3.3 Biochemical Diagnosis
    • 1.3.4 Immune Diagnosis
    • 1.3.5 Molecular Diagnosis
    • 1.3.6 Microbiological Diagnosis
    • 1.3.7 Urine Diagnosis
    • 1.3.8 Coagulation Diagnosis
    • 1.3.9 Other
  • 1.4 Global IVD Infectious Disease Market by Application
    • 1.4.1 Overview: Global IVD Infectious Disease Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Personal
    • 1.4.3 Commercial
    • 1.4.4 Academic
    • 1.4.5 Other
  • 1.5 Global IVD Infectious Disease Market Size & Forecast
  • 1.6 Global IVD Infectious Disease Market Size and Forecast by Region
    • 1.6.1 Global IVD Infectious Disease Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global IVD Infectious Disease Market Size by Region, (2019-2030)
    • 1.6.3 North America IVD Infectious Disease Market Size and Prospect (2019-2030)
    • 1.6.4 Europe IVD Infectious Disease Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific IVD Infectious Disease Market Size and Prospect (2019-2030)
    • 1.6.6 South America IVD Infectious Disease Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa IVD Infectious Disease Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Roche Diagnostics
    • 2.1.1 Roche Diagnostics Details
    • 2.1.2 Roche Diagnostics Major Business
    • 2.1.3 Roche Diagnostics IVD Infectious Disease Product and Solutions
    • 2.1.4 Roche Diagnostics IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Roche Diagnostics Recent Developments and Future Plans
  • 2.2 Abbott Laboratories
    • 2.2.1 Abbott Laboratories Details
    • 2.2.2 Abbott Laboratories Major Business
    • 2.2.3 Abbott Laboratories IVD Infectious Disease Product and Solutions
    • 2.2.4 Abbott Laboratories IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.3 Gen-Probe
    • 2.3.1 Gen-Probe Details
    • 2.3.2 Gen-Probe Major Business
    • 2.3.3 Gen-Probe IVD Infectious Disease Product and Solutions
    • 2.3.4 Gen-Probe IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Gen-Probe Recent Developments and Future Plans
  • 2.4 Becton Dickinson (BD)
    • 2.4.1 Becton Dickinson (BD) Details
    • 2.4.2 Becton Dickinson (BD) Major Business
    • 2.4.3 Becton Dickinson (BD) IVD Infectious Disease Product and Solutions
    • 2.4.4 Becton Dickinson (BD) IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Becton Dickinson (BD) Recent Developments and Future Plans
  • 2.5 Bio-Rad Laboratories
    • 2.5.1 Bio-Rad Laboratories Details
    • 2.5.2 Bio-Rad Laboratories Major Business
    • 2.5.3 Bio-Rad Laboratories IVD Infectious Disease Product and Solutions
    • 2.5.4 Bio-Rad Laboratories IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.6 Siemens Healthcare
    • 2.6.1 Siemens Healthcare Details
    • 2.6.2 Siemens Healthcare Major Business
    • 2.6.3 Siemens Healthcare IVD Infectious Disease Product and Solutions
    • 2.6.4 Siemens Healthcare IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Siemens Healthcare Recent Developments and Future Plans
  • 2.7 Biomérieux
    • 2.7.1 Biomérieux Details
    • 2.7.2 Biomérieux Major Business
    • 2.7.3 Biomérieux IVD Infectious Disease Product and Solutions
    • 2.7.4 Biomérieux IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Biomérieux Recent Developments and Future Plans
  • 2.8 Danaher
    • 2.8.1 Danaher Details
    • 2.8.2 Danaher Major Business
    • 2.8.3 Danaher IVD Infectious Disease Product and Solutions
    • 2.8.4 Danaher IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Danaher Recent Developments and Future Plans
  • 2.9 Thermo Fisher
    • 2.9.1 Thermo Fisher Details
    • 2.9.2 Thermo Fisher Major Business
    • 2.9.3 Thermo Fisher IVD Infectious Disease Product and Solutions
    • 2.9.4 Thermo Fisher IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Thermo Fisher Recent Developments and Future Plans
  • 2.10 Sysmex
    • 2.10.1 Sysmex Details
    • 2.10.2 Sysmex Major Business
    • 2.10.3 Sysmex IVD Infectious Disease Product and Solutions
    • 2.10.4 Sysmex IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Sysmex Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global IVD Infectious Disease Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of IVD Infectious Disease by Company Revenue
    • 3.2.2 Top 3 IVD Infectious Disease Players Market Share in 2023
    • 3.2.3 Top 6 IVD Infectious Disease Players Market Share in 2023
  • 3.3 IVD Infectious Disease Market: Overall Company Footprint Analysis
    • 3.3.1 IVD Infectious Disease Market: Region Footprint
    • 3.3.2 IVD Infectious Disease Market: Company Product Type Footprint
    • 3.3.3 IVD Infectious Disease Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global IVD Infectious Disease Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global IVD Infectious Disease Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global IVD Infectious Disease Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global IVD Infectious Disease Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America IVD Infectious Disease Consumption Value by Type (2019-2030)
  • 6.2 North America IVD Infectious Disease Consumption Value by Application (2019-2030)
  • 6.3 North America IVD Infectious Disease Market Size by Country
    • 6.3.1 North America IVD Infectious Disease Consumption Value by Country (2019-2030)
    • 6.3.2 United States IVD Infectious Disease Market Size and Forecast (2019-2030)
    • 6.3.3 Canada IVD Infectious Disease Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico IVD Infectious Disease Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe IVD Infectious Disease Consumption Value by Type (2019-2030)
  • 7.2 Europe IVD Infectious Disease Consumption Value by Application (2019-2030)
  • 7.3 Europe IVD Infectious Disease Market Size by Country
    • 7.3.1 Europe IVD Infectious Disease Consumption Value by Country (2019-2030)
    • 7.3.2 Germany IVD Infectious Disease Market Size and Forecast (2019-2030)
    • 7.3.3 France IVD Infectious Disease Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom IVD Infectious Disease Market Size and Forecast (2019-2030)
    • 7.3.5 Russia IVD Infectious Disease Market Size and Forecast (2019-2030)
    • 7.3.6 Italy IVD Infectious Disease Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific IVD Infectious Disease Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific IVD Infectious Disease Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific IVD Infectious Disease Market Size by Region
    • 8.3.1 Asia-Pacific IVD Infectious Disease Consumption Value by Region (2019-2030)
    • 8.3.2 China IVD Infectious Disease Market Size and Forecast (2019-2030)
    • 8.3.3 Japan IVD Infectious Disease Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea IVD Infectious Disease Market Size and Forecast (2019-2030)
    • 8.3.5 India IVD Infectious Disease Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia IVD Infectious Disease Market Size and Forecast (2019-2030)
    • 8.3.7 Australia IVD Infectious Disease Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America IVD Infectious Disease Consumption Value by Type (2019-2030)
  • 9.2 South America IVD Infectious Disease Consumption Value by Application (2019-2030)
  • 9.3 South America IVD Infectious Disease Market Size by Country
    • 9.3.1 South America IVD Infectious Disease Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil IVD Infectious Disease Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina IVD Infectious Disease Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa IVD Infectious Disease Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa IVD Infectious Disease Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa IVD Infectious Disease Market Size by Country
    • 10.3.1 Middle East & Africa IVD Infectious Disease Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey IVD Infectious Disease Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia IVD Infectious Disease Market Size and Forecast (2019-2030)
    • 10.3.4 UAE IVD Infectious Disease Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 IVD Infectious Disease Market Drivers
  • 11.2 IVD Infectious Disease Market Restraints
  • 11.3 IVD Infectious Disease Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 IVD Infectious Disease Industry Chain
  • 12.2 IVD Infectious Disease Upstream Analysis
  • 12.3 IVD Infectious Disease Midstream Analysis
  • 12.4 IVD Infectious Disease Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on IVD Infectious Disease. Industry analysis & Market Report on IVD Infectious Disease is a syndicated market report, published as Global IVD Infectious Disease Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of IVD Infectious Disease market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,651.76
    		3,977.64
    		5,303.52
    		3,138.96
    		4,708.44
    		6,277.92
    		490,540.80
    		735,811.20
    		981,081.60
    		292,180.80
    		438,271.20
    		584,361.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo